Use of HIFU for Tremor-Dominant Parkinson’s Disease: A Patient Success Story
-
April 17, 2026
-
7 min
April 17, 2026
Dana-Farber Cancer Institute's Dr. Sara Tolaney presented a subgroup analysis of the ASCENT-04 study based on biomarkers. Across all subgroups, patients who received sacituzumab govitecan plus pembro as first-line therapy had longer progression-free survival compared to standard therapy.
July 1, 2026
Recent CDC advisories, testing updates, and immunization recommendations highlight developments in infectious diseases, immunization, and diagnostic testing relevant to physicians across multiple specialties.
July 9, 2026
A modified KN95 mask captures exhaled nitric oxide for direct miniature mass spectrometry analysis
June 16, 2026